4 Results for "

Elubrixin

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "Elubrixin" in MCE Product Catalog:

Cat. No.: HY-18263C
CAS No.: 960495-43-6
Synonyms: SB-656933 tosylate
Research Areas:  

Inflammation/Immunology

Elubrixin tosylate (SB-656933 tosylate) is a potent, selective, competitive, reversible and orally active CXCR2 antagonist and an IL-8 receptor antagonist. Elubrixin tosylate inhibits neutrophil CD11b upregulation (IC50 of 260.7 nM) and shape change (IC50 of 310.5 nM). Elubrixin tosylate has the potential for inflammatory diseases research, such as inflammatory bowel disease and airway inflammation .
loading...
    loading...
Cat. No.: HY-18263A
CAS No.: 688763-64-6
Synonyms: SB-656933
Research Areas:  

Inflammation/Immunology

Elubrixin (SB-656933) is a potent, selective, competitive, reversible and orally active CXCR2 antagonist and an IL-8 receptor antagonist. Elubrixin inhibits neutrophil CD11b upregulation (IC50 of 260.7 nM) and shape change (IC50 of 310.5 nM). Elubrixin has the potential for inflammatory diseases research, such as inflammatory bowel disease and airway inflammation .
loading...
    loading...
Cat. No.: HY-18263CR
CAS No.: 960495-43-6
Synonyms: SB-656933 tosylate (Standard)
Elubrixin (tosylate) (Standard) is the analytical standard of Elubrixin (tosylate). This product is intended for research and analytical applications. Elubrixin tosylate (SB-656933 tosylate) is a potent, selective, competitive, reversible and orally active CXCR2 antagonist and an IL-8 receptor antagonist. Elubrixin tosylate inhibits neutrophil CD11b upregulation (IC50 of 260.7 nM) and shape change (IC50 of 310.5 nM). Elubrixin tosylate has the potential for inflammatory diseases research, such as inflammatory bowel disease and airway inflammation .
loading...
    loading...
Cat. No.: HY-18263
CAS No.: 688763-65-7
Synonyms: SB-656933 hydrochloride
Research Areas:  

Inflammation/Immunology

Elubrixin (SB-656933) hydrochloride is a potent, selective, competitive, reversible and orally active CXCR2 antagonist and an IL-8 receptor antagonist. Elubrixin hydrochloride inhibits neutrophil CD11b upregulation (IC50 of 260.7 nM) and shape change (IC50 of 310.5 nM). Elubrixin hydrochloride has the potential for inflammatory diseases research, such as inflammatory bowel disease and airway inflammation .
loading...
    loading...